Mingming Xue

557 total citations
27 papers, 366 citations indexed

About

Mingming Xue is a scholar working on Epidemiology, Molecular Biology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Mingming Xue has authored 27 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 9 papers in Molecular Biology and 4 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Mingming Xue's work include Sepsis Diagnosis and Treatment (10 papers), Respiratory Support and Mechanisms (3 papers) and Immune Response and Inflammation (3 papers). Mingming Xue is often cited by papers focused on Sepsis Diagnosis and Treatment (10 papers), Respiratory Support and Mechanisms (3 papers) and Immune Response and Inflammation (3 papers). Mingming Xue collaborates with scholars based in China and United States. Mingming Xue's co-authors include Ying Yuan, Zhengang Tao, Chaoyang Tong, Jianjun Chen, Binbin Cheng, Zhenju Song, Hao Cao, Yao Xiao, Qiang Zhu and Jun Yin and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Frontiers in Immunology.

In The Last Decade

Mingming Xue

25 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingming Xue China 12 125 78 67 67 57 27 366
Hongyang Liu China 14 189 1.5× 60 0.8× 69 1.0× 87 1.3× 32 0.6× 37 528
Shang-Jyh Kao Taiwan 9 121 1.0× 90 1.2× 36 0.5× 66 1.0× 29 0.5× 12 354
Wenhao Liao China 11 227 1.8× 54 0.7× 50 0.7× 39 0.6× 72 1.3× 33 436
Ting-Hsu Lin Taiwan 14 202 1.6× 53 0.7× 60 0.9× 79 1.2× 49 0.9× 23 487
Nalini Devarajan India 12 145 1.2× 35 0.4× 32 0.5× 77 1.1× 48 0.8× 20 408
Molly M. Hood United States 9 128 1.0× 81 1.0× 78 1.2× 14 0.2× 62 1.1× 19 421
Kui Yang China 15 133 1.1× 99 1.3× 57 0.9× 107 1.6× 26 0.5× 31 538
Qingfei Xiao China 14 206 1.6× 136 1.7× 26 0.4× 176 2.6× 99 1.7× 23 589
Ellen Cristina Souza de Oliveira Brazil 7 186 1.5× 28 0.4× 67 1.0× 42 0.6× 20 0.4× 11 369

Countries citing papers authored by Mingming Xue

Since Specialization
Citations

This map shows the geographic impact of Mingming Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingming Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingming Xue more than expected).

Fields of papers citing papers by Mingming Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingming Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingming Xue. The network helps show where Mingming Xue may publish in the future.

Co-authorship network of co-authors of Mingming Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Mingming Xue. A scholar is included among the top collaborators of Mingming Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingming Xue. Mingming Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
3.
Xue, Mingming, Shuai Zhang, Jianing Wang, et al.. (2024). Chemoenzymatic synthesis of sialyl-α2,3-lactoside–functionalized BSA conjugate inhibits influenza infection. European Journal of Medicinal Chemistry. 276. 116633–116633. 1 indexed citations
4.
Xue, Mingming, et al.. (2024). A Zanamivir-protein conjugate mimicking mucin for trapping influenza virion particles and inhibiting neuraminidase activity. International Journal of Biological Macromolecules. 275(Pt 1). 133564–133564. 2 indexed citations
5.
Li, Fang, et al.. (2023). Polydatin alleviates sepsis‑induced acute lung injury via downregulation of Spi‑B. Biomedical Reports. 19(6). 102–102. 1 indexed citations
6.
Cheng, Shenhang, Caihong Yu, Mingming Xue, et al.. (2022). Toxicity and risk assessment of nine pesticides on nontarget natural predator Harmonia axyridis (Coleoptera: Coccinellidae). Pest Management Science. 78(12). 5124–5132. 9 indexed citations
7.
Mu, Sucheng, Xiang Hao, Yuezhu Wang, et al.. (2022). The pathogens of secondary infection in septic patients share a similar genotype to those that predominate in the gut. Critical Care. 26(1). 68–68. 29 indexed citations
8.
Wang, Jianli, Yanyan Hu, Chen Yao, et al.. (2022). GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response. Frontiers in Immunology. 12. 789141–789141. 5 indexed citations
9.
Zhang, Wen, Zhenju Song, Mingming Xue, et al.. (2022). Berberine suppresses cecal ligation and puncture induced intestinal injury by enhancing Treg cell function. International Immunopharmacology. 106. 108564–108564. 6 indexed citations
10.
Yin, Jun, Chen Yao, Lei Yan, et al.. (2021). Prognosis-related classification and dynamic monitoring of immune status in patients with sepsis: A prospective observational study. World Journal of Emergency Medicine. 12(3). 185–185. 11 indexed citations
12.
Ren, Yichang, Mingming Xue, Binbin Cheng, et al.. (2021). Design, synthesis and biological evaluation of benz‐fused five‐membered heterocyclic compounds as tubulin polymerization inhibitors with anticancer activities. Chemical Biology & Drug Design. 97(5). 1109–1116. 8 indexed citations
13.
Cheng, Binbin, et al.. (2020). Discovery of novel CA-4 analogs as dual inhibitors of tubulin polymerization and PD-1/PD-L1 interaction for cancer treatment. European Journal of Medicinal Chemistry. 213. 113058–113058. 28 indexed citations
14.
Yin, Jun, Keyong Li, Mingming Xue, et al.. (2018). Clinical characteristics and prognosis of serous body cavity effusions in patients with sepsis: a retrospective observational study. BMC Anesthesiology. 18(1). 169–169. 11 indexed citations
15.
Yuan, Ying, Mingming Xue, Yujing Shi, et al.. (2018). Shufeng Jiedu Capsules Alleviate Lipopolysaccharide-Induced Acute Lung Inflammatory Injury via Activation of GPR18 by Verbenalin. Cellular Physiology and Biochemistry. 50(2). 629–639. 29 indexed citations
16.
Tao, Zhengang, Yanqi Han, Mingming Xue, et al.. (2017). Therapeutic Mechanistic Studies of ShuFengJieDu Capsule in an Acute Lung Injury Animal Model Using Quantitative Proteomics Technology. Journal of Proteome Research. 16(11). 4009–4019. 41 indexed citations
17.
Yuan, Ying, et al.. (2017). Emodin: One Main Ingredient of Shufeng Jiedu Capsule Reverses Chemoresistance of Lung Cancer Cells Through Inhibition of EMT. Cellular Physiology and Biochemistry. 42(3). 1063–1072. 23 indexed citations
18.
Xue, Mingming, Zhan Sun, Jun Yin, et al.. (2015). Diagnostic and prognostic utility of tissue factor for severe sepsis and sepsis-induced acute lung injury. Journal of Translational Medicine. 13(1). 172–172. 44 indexed citations
19.
Song, Zhenju, Jun Yin, Mingming Xue, et al.. (2014). Genetic variation in the tissue factor gene is associated with clinical outcome in severe sepsis patients. Critical Care. 18(6). 631–631. 5 indexed citations
20.
Tao, Zhengang, et al.. (2014). Shufeng Jiedu Capsule protect against acute lung injury by suppressing the MAPK/NF-κB pathway. BioScience Trends. 8(1). 45–51. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026